Skip to main content
SpringerLink
Log in

Emerging therapies drive growth in melanoma market

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources Inc.Emerging Therapies, Including Bristol-Myers Squibb/Medarex's Ipilimumab, Will Drive Growth in the Malignant Melanoma Drug Market. Media Release: 15 Sep 2008. Available from: URL: http://www.decisionresourcesinc.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Emerging therapies drive growth in melanoma market. Pharmacoecon. Outcomes News 563, 10 (2008). https://doi.org/10.2165/00151234-200805630-00022

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805630-00022

Keywords

Search

Navigation